Microsoft Immunomics
Learning to read the immune system
News & features
In the news | NewsCo Shift
All we have yet to understand
I believe that all reality is information, and all information creates reality. I am not alone in this belief, but it is nevertheless controversial. Regardless, around this maddening thesis revolves nearly all the intractable problems, paradoxes, and opportunities of modern…
In the news | The Seattle Times
Microsoft invests in Adaptive Biotechnologies to develop blood test to detect diseases
Microsoft’s partnership with Seattle-based Adaptive Biotechnologies will focus on mapping and understanding people’s immune-system responses so that illnesses can be found quickly.
In the news | GenomeWeb
Microsoft, Adaptive Biotechnologies Partner to Study Immune System Genetics
NEW YORK (GenomeWeb) – Adaptive Biotechnologies announced today that it has partnered with Microsoft to map the genetics of the human immune system, with the aim of detecting cancers and other disease in their earliest stages.
In the news | siliconrepublic
Microsoft to use AI to predict hundreds of illnesses from single blood test
The aim is to create a single blood test that could be trained to identify potentially hundreds of illnesses in the immune system before they present themselves as symptoms.
In the news | BusinessWire
Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease
Adaptive Biotechnologies, a leader in next-generation sequencing of T- and B-cell receptors of the adaptive immune system, announced today their partnership with Microsoft to map the genetics of the human immune system to detect cancers and other diseases in their…
Awards | HIV Vaccine Trials Network
Jonathan Carlson receives inaugural Bonnie Mathieson Young Investigator Award
The HIV Vaccine Trials Network (opens in new tab) honored Jonathan Carlson with an inaugural Bonnie Mathieson Young Investigator Award for his leading role in research that leveraged machine learning and the trials network’s data to show how HIV variants that are pre-adapted…